C. Andrew Kistler, MD, PharmD

Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.

Most Recent Articles by C. Andrew Kistler, MD, PharmD

Bowel Preparation for Colorectal Cancer Screening: Improving Outcomes

Bowel Preparation for Colorectal Cancer Screening: Improving Outcomes

By

Stool burden can be a particularly challenging aspect of colonoscopies, making potentially cancerous lesions easier to miss.

Tool for Assessing Frailty Predicts Survival in Newly Diagnosed Multiple Myeloma

Tool for Assessing Frailty Predicts Survival in Newly Diagnosed Multiple Myeloma

By

A patient's frailty has been determined to be associated with a higher likelihood of developing toxicities, a poor therapeutic response, and decreased survival.

Obinutuzumab in Follicular Lymphoma

Obinutuzumab in Follicular Lymphoma

By

Many patients with follicular lymphoma will be asymptomatic and present with variable cervical, axillary, and inguinal adenopathy.

Selinexor and Multiple Myeloma

Selinexor and Multiple Myeloma

By

Early preclinical and clinical data have shown that selinexor has broad activity against multiple hematologic malignancies and notable antimyeloma activity.

Aspirin and Colorectal Cancer

Aspirin and Colorectal Cancer

By

Studies attempting to link ASA to a reduction in the risk of CRC have had mixed results.

More Articles by C. Andrew Kistler, MD, PharmD

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs